RedHill Biopharma (RDHL) Return on Equity (2014)
RedHill Biopharma (RDHL) reported Return on Equity of 0.01% for Q4 2014, up 1019.41% quarter-over-quarter from 0.0% in Q1 2014.
RedHill Biopharma (RDHL) Return on Equity (2014) Analysis & Trends
RedHill Biopharma (RDHL) has 1 years of Return on Equity data on file, last reported at 0.01% in Q4 2014.
- Return on Equity for Q4 2014 came in at 0.01%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2014 was 0.01% (changed N/A YoY), and the FY2025 annual result was 0.37%, down 43.0% from the prior year.
- Return on Equity climbed to 0.01% in Q4 2014 per RDHL's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Equity peaked at 0.01% in Q4 2014 and troughed at 0.0% in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.00% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 0.01% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 0.00% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.00% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 0.00% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.00% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 0.00% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 0.00% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 0.00% |
| 10 | RedHill Biopharma | 142.34 Mn | 142.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 0.01% |
| Mar 31, 2014 | 0.00% |